Commit To Purchase Blueprint Medicines Corp At $15, Earn 32.4% Annualized Using Options

Investors eyeing a purchase of Blueprint Medicines Corp (BPMC) stock, but tentative about paying the going market price of $17.95/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $15 strike, which has a bid at the time of this writing of $2.05..